Management of High-risk and Advanced Basal Cell Carcinoma

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2015 Feb 4

PMID 25643667

Citations 33

Authors

S Puig

A Berrocal

Affiliations

Soon will be listed here.

Abstract

Despite that basal cell carcinoma (BCC) is curative in the vast majority of cases, some patients are at high risk of recurrence and, in a few patients, lesions can progress to a point unsuitable for local therapy and prognosis is quite poor. The aim of the present work is to review clinical and pathologic characteristics as well as classical and new treatment options for high-risk, metastatic and locally advanced BCC. Surgery and radiotherapy remain the selected treatments for the majority of high-risk lesions. However, some patients are located on a blurry clinical boundary between high-risk and locally advanced BCC. Treatment of these patients is challenging and need an individualized and highly specialized approach. The treatment of locally advanced BCC, in which surgery or radiotherapy is unfeasible, inappropriate or contraindicated, and metastatic BCC has changed with new Hedgehog pathway inhibitors of which vismodegib is the first drug approved by FDA and EMA.

Citing Articles

10 Years of Mohs Micrographic Surgery in Denmark: Results from a Nationwide Cohort.

Andersen Y, Karmisholt K, Hogsberg T, Nielsen M, Brosbol A, Stave S Acta Derm Venereol. 2025; 105():adv41118.

PMID: 39791512 PMC: 11744706. DOI: 10.2340/actadv.v105.41118.

The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinoma: long-term results.

Vass A, Polgar N, Sandor S, Agoston D, Rozsa P, Csanyi I Int J Dermatol. 2024; 64(1):111-118.

PMID: 38924059 PMC: 11685057. DOI: 10.1111/ijd.17346.

Exploring multisite heterogeneity of human basal cell carcinoma proteome and transcriptome.

Berl A, Shir-Az O, Genish I, Biran H, Mann D, Singh A PLoS One. 2023; 18(11):e0293744.

PMID: 37948379 PMC: 10637653. DOI: 10.1371/journal.pone.0293744.

The impact of the COVID-19 pandemic on the diagnosis and treatment of skin cancers, a mini review.

Aryanian Z, Balighi K, Goodarzi A, Sadeghi Nia A, Mohseni Afshar Z, Hatami P Cancer Rep (Hoboken). 2023; 6(9):e1854.

PMID: 37434543 PMC: 10480421. DOI: 10.1002/cnr2.1854.

Review of the Tumor Microenvironment in Basal and Squamous Cell Carcinoma.

Chiang E, Stafford H, Buell J, Ramesh U, Amit M, Nagarajan P Cancers (Basel). 2023; 15(9).

PMID: 37173918 PMC: 10177565. DOI: 10.3390/cancers15092453.

References

Mencia-Gutierrez E, Gutierrez-Diaz E, Perez-Martin M . Lacrimal caruncle primary basal cell carcinoma: case report and review. J Cutan Pathol. 2005; 32(7):502-5. DOI: 10.1111/j.0303-6987.2005.00300.x. View

Dandurand M, Petit T, Martel P, Guillot B . Management of basal cell carcinoma in adults Clinical practice guidelines. Eur J Dermatol. 2006; 16(4):394-401. View

Nemet A, Deckel Y, Martin P, Kourt G, Chilov M, Sharma V . Management of periocular basal and squamous cell carcinoma: a series of 485 cases. Am J Ophthalmol. 2006; 142(2):293-7. DOI: 10.1016/j.ajo.2006.03.055. View

Carneiro B, Watkin W, Mehta U, Brockstein B . Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest. 2006; 24(4):396-400. DOI: 10.1080/07357900600705474. View

Telfer N, Colver G, Morton C . Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008; 159(1):35-48. DOI: 10.1111/j.1365-2133.2008.08666.x. View

Majima Y, Hirakawa S, Kito Y, Suzuki H, Koide M, Fukamizu H . Twist1 as a possible biomarker for metastatic basal cell carcinoma. Acta Derm Venereol. 2012; 92(6):621-2. DOI: 10.2340/00015555-1422. View

Gailani M, Leffell D, Ziegler A, GROSS E, Brash D, Bale A . Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst. 1996; 88(6):349-54. DOI: 10.1093/jnci/88.6.349. View

Varga E, Korom I, Rasko Z, Kis E, Varga J, Olah J . Neglected Basal cell carcinomas in the 21st century. J Skin Cancer. 2010; 2011:392151. PMC: 2993023. DOI: 10.1155/2011/392151. View

Nassab R, Thomas S, Murray D . Orbital exenteration for advanced periorbital skin cancers: 20 years experience. J Plast Reconstr Aesthet Surg. 2007; 60(10):1103-9. DOI: 10.1016/j.bjps.2007.02.012. View

10.

Berlin J, Warner M, Bailin P . Metastatic basal cell carcinoma presenting as unilateral axillary lymphadenopathy: report of a case and review of the literature. Dermatol Surg. 2002; 28(11):1082-4. DOI: 10.1046/j.1524-4725.2002.02090.x. View

11.

Jefford M, Kiffer J, Somers G, Daniel F, Davis I . Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004; 74(8):704-5. DOI: 10.1111/j.1445-1433.2004.03130.x. View

12.

Bozikov K, Taggart I . Metastatic basal cell carcinoma: is infiltrative/morpheaform subtype a risk factor?. Eur J Dermatol. 2007; 16(6):691-2. View

13.

Domarus H, Stevens P . Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984; 10(6):1043-60. DOI: 10.1016/s0190-9622(84)80334-5. View

14.

Connolly S, Baker D, Coldiron B, Fazio M, Storrs P, Vidimos A . AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for.... J Am Acad Dermatol. 2012; 67(4):531-50. DOI: 10.1016/j.jaad.2012.06.009. View

15.

Boulinguez S, Grison-Tabone C, Lamant L, Valmary S, Viraben R, Bonnetblanc J . Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol. 2004; 151(3):623-6. DOI: 10.1111/j.1365-2133.2004.06135.x. View

16.

Guthrie Jr T, McElveen L, Porubsky E, Harmon J . Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer. 1985; 55(8):1629-32. DOI: 10.1002/1097-0142(19850415)55:8<1629::aid-cncr2820550802>3.0.co;2-i. View

17.

Mendenhall W, Amdur R . Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage. Am J Otolaryngol. 2001; 22(6):387-90. DOI: 10.1053/ajot.2001.28083. View

18.

Irvine C, Walker N, Ramnarain N, Downes R, Collin J . Micrographically controlled excision (Mohs' surgery) of basal cell carcinoma around the eye. Combined dermatological surgical clearance and oculoplastic surgical repair. Aust N Z J Ophthalmol. 1992; 20(1):5-10. DOI: 10.1111/j.1442-9071.1992.tb00696.x. View

19.

Wadhera A, Fazio M, Bricca G, Stanton O . Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data?. Dermatol Online J. 2006; 12(5):7. View

20.

Epstein E . Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008; 8(10):743-54. PMC: 4457317. DOI: 10.1038/nrc2503. View